Rezolsta Európai Unió - dán - EMA (European Medicines Agency)

rezolsta

janssen-cilag international n.v. - darunavir, cobicistat - hiv infektioner - antivirals for systemic use, antivirals for treatment of hiv infections, combinations - rezolsta, er indiceret i kombination med andre antiretrovirale lægemidler til behandling af human immunodeficiency virus 1 (hiv 1) infektion hos voksne i alderen 18 år eller derover. genotypiske test bør vejlede i brugen af rezolsta.

Juluca Európai Unió - dán - EMA (European Medicines Agency)

juluca

viiv healthcare b.v. - dolutegravir natrium, rilpivirine hydrochlorid - hiv infektioner - antivirale midler til systemisk anvendelse - juluca er indiceret til behandling af human immundefekt virus type 1 (hiv-1) - infektion hos voksne, der er virologically-undertrykt (hiv-1 rna.

Sunlenca Európai Unió - dán - EMA (European Medicines Agency)

sunlenca

gilead sciences ireland unlimited company - lenacapavir sodium - hiv infektioner - antivirale midler til systemisk anvendelse - sunlenca injection, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen (see sections 4. 2 og 5. sunlenca tablet, in combination with other antiretroviral(s), is indicated for the treatment of adults with multidrug resistant hiv 1 infection for whom it is otherwise not possible to construct a suppressive anti viral regimen, for oral loading prior to administration of long-acting lenacapavir injection (see sections 4. 2 og 5.

Duomevolen 200+245 mg filmovertrukne tabletter Dánia - dán - Lægemiddelstyrelsen (Danish Medicines Agency)

duomevolen 200+245 mg filmovertrukne tabletter

amneal pharma europe limited - emtricitabin, tenofovir disoproxilphosphat - filmovertrukne tabletter - 200+245 mg